Cargando…
Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977187/ https://www.ncbi.nlm.nih.gov/pubmed/35377105 http://dx.doi.org/10.1007/s13577-022-00697-2 |
| _version_ | 1784680715280973824 |
|---|---|
| author | Zalpoor, Hamidreza Akbari, Abdullatif Nabi-Afjadi, Mohsen |
| author_facet | Zalpoor, Hamidreza Akbari, Abdullatif Nabi-Afjadi, Mohsen |
| author_sort | Zalpoor, Hamidreza |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8977187 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89771872022-04-04 Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases Zalpoor, Hamidreza Akbari, Abdullatif Nabi-Afjadi, Mohsen Hum Cell Letter to the Editor Springer Nature Singapore 2022-04-04 2022 /pmc/articles/PMC8977187/ /pubmed/35377105 http://dx.doi.org/10.1007/s13577-022-00697-2 Text en © The Author(s) under exclusive licence to Japan Human Cell Society 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Zalpoor, Hamidreza Akbari, Abdullatif Nabi-Afjadi, Mohsen Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases |
| title | Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases |
| title_full | Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases |
| title_fullStr | Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases |
| title_full_unstemmed | Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases |
| title_short | Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases |
| title_sort | ephrin (eph) receptor and downstream signaling pathways: a promising potential targeted therapy for covid‑19 and associated cancers and diseases |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977187/ https://www.ncbi.nlm.nih.gov/pubmed/35377105 http://dx.doi.org/10.1007/s13577-022-00697-2 |
| work_keys_str_mv | AT zalpoorhamidreza ephrinephreceptoranddownstreamsignalingpathwaysapromisingpotentialtargetedtherapyforcovid19andassociatedcancersanddiseases AT akbariabdullatif ephrinephreceptoranddownstreamsignalingpathwaysapromisingpotentialtargetedtherapyforcovid19andassociatedcancersanddiseases AT nabiafjadimohsen ephrinephreceptoranddownstreamsignalingpathwaysapromisingpotentialtargetedtherapyforcovid19andassociatedcancersanddiseases |